People with a leading cause of blindness were able to read again thanks to a tiny wireless chip implanted in the back of the eye and specialized augmented glasses, according to study results published Monday in the New England Journal of Medicine.  ​​People with a leading cause of blindness were able to read again thanks to…

 A cognitive training program may boost production of a brain chemical that plays a vital role in memory and attention, a new study finds.  ​​A cognitive training program may boost production of a brain chemical that plays a vital role in memory and attention, a new study finds. 

 Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment  ​​Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune…

 The measles outbreak among children in South Carolina is still growing, even though a small number of the quarantined school kids have been allowed back in class.  ​​The measles outbreak among children in South Carolina is still growing, even though a small number of the quarantined school kids have been allowed back in class. 

 After a rough, record-setting flu season, doctors and health officials are bracing for another wave of fever, misery and respiratory distress.  ​​After a rough, record-setting flu season, doctors and health officials are bracing for another wave of fever, misery and respiratory distress. 

 President Donald Trump announced a deal with the maker of a common IVF drug, which pledged to sell its fertility medications at a discount through the direct-to-consumer TrumpRx website.  ​​President Donald Trump announced a deal with the maker of a common IVF drug, which pledged to sell its fertility medications at a discount through the direct-to-consumer…

 New research found that gene therapy for children with “bubble boy disease,” or SCID, was successful in 95% of trial participants.  ​​New research found that gene therapy for children with “bubble boy disease,” or SCID, was successful in 95% of trial participants.